During the last session, enVVeno Medical Corporation (NASDAQ:NVNO)’s traded shares were 0.13 million, with the beta value of the company hitting 0.92. At the end of the trading day, the stock’s price was $4.13, reflecting an intraday loss of -3.73% or -$0.16. The 52-week high for the NVNO share is $6.48, that puts it down -56.9 from that peak though still a striking 50.85% gain since the share price plummeted to a 52-week low of $2.03. The company’s market capitalization is $72.42M, and the average intraday trading volume over the past 10 days was 0.2 million shares, and the average trade volume was 99.89K shares over the past three months.

enVVeno Medical Corporation (NASDAQ:NVNO) trade information

enVVeno Medical Corporation (NVNO) registered a -3.73% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.73% in intraday trading to $4.13, hitting a weekly high. The stock’s 5-day price performance is -8.02%, and it has moved by 13.77% in 30 days. Based on these gigs, the overall price performance for the year is -13.42%. The short interest in enVVeno Medical Corporation (NASDAQ:NVNO) is 0.47 million shares and it means that shorts have 5.44 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 36.26%. While earnings are projected to return 14.96% in 2025, the next five years will return 16.48% per annum.

NVNO Dividends

enVVeno Medical Corporation is due to release its next quarterly earnings on 2025-Apr-30. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 0.62 million shares, is of PERCEPTIVE ADVISORS LLC’s that is approximately 3.8795% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.27 million.